Salubris, established in 1998, with our philosophy: Keeping Promises Is the Source of Happiness, is the leader in cardiovascular and anti-infectious products with turnover USD $ 446 million in 2013. Salubris is famouse for the 1st launcher of Clopidogrel and Bivalirudin in China. Almost all main products are first-to-market, with market share in the top 3 position. We also obtained EU GMP for OSD and EU GMP for Injiection projects are on-going. Salubris has a subsidiary in Germany, Splendris Pharmaceuticals GmbH, which holds MAs in EU. We are interested in out-licensing, contract manufacturing and in-licensing etc.. Brian is accountable for the marketing and sales activities for Salubris's FDFs worldwide. Main responsibilities are: (1) Looking for agents for Salubris's FDFs worldwide: Clopidogrel, Bivalirudin, Benazepril, Desloratadine, Azithromycin, Pamidronate, Ciclosporin, Cefoxitin, Cefepime, Cefuroxime etc., (2)Looking for out-licensing opportunities for Salubris's FDFs worldwide: Allisartan, Bivalirudin, Lercanidipine, Fluvastatin, Levetiracetam, Mycophenolate etc., (3) Looking for CMO opportunities for worldwide including: injection, powder for injection, lyophilized powder for injection, oral solid dosage etc., (4) Product launch and promotion, (5) Market Research, brand promotion and management.

Brian is accountable for the marketing and sales activities in EU market. Main responsibilities are: (1) Business development (Contract Manufacturing service),(2) Coordination with API suppliers,(3) Product launch and promotion,(4) Market Research, brand promotion and management.

Brian was accountable for the market research of Japan & Kenya. Main responsibilities were: (1) Pharmaceutical market research of Japan & Kenya(2) Sought for potential customers overseas